Merck
  • Home
  • Search Results
  • [The intracellular metabolism of neutrophils under different forms of ischemic heart disease].

[The intracellular metabolism of neutrophils under different forms of ischemic heart disease].

Klinicheskaia laboratornaia diagnostika (2013-03-14)
A E Kratnov
ABSTRACT

The article deals with the results of study of the intracellular metabolism of neutrophils in 96 patients including 56 (58.3%) patients with ischemic heart disease. It is established that in patients with ischemic heart disease as compared with patients without ischemic heart disease occurs the increase of neutrophils producing of active forms of oxygen against the background of decrease of intracellular activity of catalase and increase of concentration of lactate in phagocytes. Under severing of ischemic heart disease from unstable stenocardia to cardiac infarction the activation of oxygen-depending metabolism of neutrophils conditioned by increase of concentration of immune complexes circulating in blood was not compensated by increasing of intracellular activity of enzymes of system of antioxidant defense. The maximum activation of NAD(F)N-oxidase of neutrophils (production of superoxide anion-radical) was detected in patients with cardiac infarction with Q-wave. This condition was accompanied by maximal increase of concentration of lactate in phagocytes up to twice higher exceed the level of indicators in patients without ischemic heart disease. It can be assumed that in conditions of acute hypoxia occurring under myocardium ischemia in patients with ischemic heart disease, the lactate production increases in neutrophils hence the triggering of development of intracellular acidosis, impact of oxygen-depending factors and phagocytes destruction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glutathione Reductase human, buffered aqueous solution, ≥10 units/mg protein, recombinant, expressed in E. coli
Sigma-Aldrich
Catalase from Aspergillus niger, ammonium sulfate suspension, ≥4,000 units/mg protein
Sigma-Aldrich
Catalase from human erythrocytes, ≥90% (SDS-PAGE), buffered aqueous solution, ≥30,000 units/mg protein
Sigma-Aldrich
Catalase from bovine liver, lyophilized powder, 2,000-5,000 units/mg protein
Sigma-Aldrich
Catalase from bovine liver, aqueous suspension, 10,000-40,000 units/mg protein
Sigma-Aldrich
Catalase from bovine liver, powder, suitable for cell culture, 2,000-5,000 units/mg protein
Sigma-Aldrich
Catalase from bovine liver, aqueous solution, ≥30,000 units/mg protein
Sigma-Aldrich
Catalase from bovine liver, lyophilized powder, ≥10,000 units/mg protein
Sigma-Aldrich
Catalase from bovine liver, aqueous suspension, 40,000-60,000 units/mg protein (E1%/405)
Sigma-Aldrich
Catalase from Corynebacterium glutamicum, solution, deep brown, ≥500000 U/mL